Acid blockers are often prescribed, either for burning, stomach inflammation, nausea or simply as protective protection of the stomach. Unfortunately, popular drugs are not harmless. Especially if you take them long term, many side effects can occur. The lack of minerals with an increased risk of bone fracture is only possible, such as kidney damage, bacterial infections and allergies. For a long time it was suspected that acid blockers also damage the liver, this has now been confirmed. Confirmed, safe, stress in the liver
Acid blockers appear to cause massive liver stress and researchers may appear in California in October 2017.
If you have also labeled acid blockers or the so-called gastric protection due to stomach problems or simply “alone” along with an antibiotic or analgesic treatment, look at the package. If there is a name with the end of the drug – prazole (for example, omeprazole, pantoprazole, lansoprazole, etc.), then swallow proton-blocking inhibitor (PPI).
PPI among the 3 best prescription medications
According to the Drug Disposal report, these acid blockers ranked third in the most widely prescribed treatments, before antihypertensive drugs and statins. This means that they are taken millions of times and generate millions of profits for the pharmaceutical industry. Only Americans spend $ 11 billion a year on acid blockers alone.
However, the PPI indicators are not only a source of great joy for the pharmaceutical giant when selling money, but also due to the resulting complications, which must be treated with other drugs.
PPI is valid for three chronic liver diseases
We have already described the numerous side effects of acid blockers here: acid citrate increases the risk of death. These include a lack of vital materials and multiple consequences, and food intolerance, and chronic kidney disease, increased risk of infection, indigestion, and when pregnant women are exposed to PPI disease, increases the risk of allergies and asthma in the child
It has also been observed that the use of long-term PPI exacerbates liver function. Researchers show at the University of California / San Diego note that acid blockers can affect the intestinal flora in such a way that this state now lead to three different chronic liver disease: nonalcoholic fatty liver disease, (non-alcoholic) liver steatohepatitis inflammation) and liver acceleration associated with alcohol damage.
Tragically, people with liver disease often take hepatic blockers, so they do not become healthier, as they expect, but they are increasing their health more and more. Deep blockers allow harmful bacteria to migrate through the body.
In Nature Communications (October 2017), researchers wrote in California about Dr. Ing. Bernd Chenbl, Professor of Gastroenterology: “If our stomach, among other things, to kill the form of stomach acid bacteria produced by food If you are taking medications that inhibit the formation of acid, these bacteria survive and multiply. ”
Already in 2014, a study (JAMA Pediatrics) showed that the use of acid blockers in children increased bacterial growth in the stomach. But the bacteria do not stay in the stomach. “From the stomach, bacteria finally reach the lymph nodes and intestines, and finally change the composition of the intestinal flora.”
Now there is a so-called spread. Intestinal bacteria This migration is carried out through the intestinal mucosa in the blood and directly in the liver, where it produces inflammation or improvement of the existing liver conditions. Those who drink too much alcohol and at the same time take PPI to develop liver disease faster than alcohol alone.
It was already known that the condition of the intestinal flora could affect the risk of liver disease. This study confirms again these previous findings.
Liver disease has become more common
Cirrhosis is one of the most common causes of death worldwide, with only half of all cases of cirrhosis associated with alcohol. An important cause of general liver disease is weight gain, which can lead to non-alcoholic fatty liver and non-alcoholic fatty liver disease (NASH).